New research sheds light on how ketamine affects the brain by targeting a specific NMDA receptor subtype, GluN1-2B-2D.

In a new study, Cold Spring Harbor Laboratory Professor Hiro Furukawa and postdoc Hyunook Kang prove the existence of a mysterious brain receptor known as GluN1-2B-2D. They also show several ways the ...

Olfactive Biosolutions, the leader in adapting food molecules to treat chronic diseases, was recently granted U.S. patent US 12,186,299 dated Jan. 7, 2025, Compositions And Methods For Treating ...

Startup Canaery is partnering with a US Department of Energy lab to develop neural implants for rats and dogs that are ...

“The formulation activates ectopic olfactory receptors OR51E1 and OR51E2 ... Olfactive Biosolutions is the leader in adapting food molecules to treat chronic diseases; it now has a total ...

Most major biological molecules, including all proteins, DNA and RNA, point in one direction or another. In other words, they ...

Understanding why we always have room for dessert could lead to new treatments for obesity, researchers have revealed.

Who hasn't been there? The big meal is over, you're full, but the craving for sweets remains. Researchers from the Max Planck ...

Atherosclerotic cardiovascular disease is a major health concern worldwide and requires effective preventive measures. Lp(a) (lipoprotein [a]) has recently garnered attention as an independent risk ...

Researchers at Leipzig University’s Faculty of Medicine and Shandong University in China have discovered a new mechanism that ...